About HeartSciences

HeartSciences combines current research and understanding of heart disease along with the latest advances in wavelet signal processing and artificial Intelligence to develop breakthrough technology for the early detection of heart disease*.

Formed in 2008, HeartSciences (formerly known as Heart Test Laboratories) is a privately held medical technology company located in the Dallas-Fort Worth metroplex, the largest economic area in the Southern United States. For a decade, HeartSciences has been dedicated to the development of accurate, affordable cardiac testing tools for the early detection of heart disease*.

To date, HeartSciences has invested more than $30M in research and development in an effort to improve the sensitivity of an electrocardiograph (ECG/EKG) for the early detection of heart disease*.

MyoVista® Wavelet ECG (wavECG™) Technology applies proprietary use of Continuous Wavelet Transform (CWT) signal processing and represents HeartSciences first product release from years of research and development.

*MyoVista® Wavelet ECG provides clinically-relevant reproducible and quantitative data intended to be used to support qualified cardiologist and other licensed healthcare professionals for clinical decision-making. It is a support tool that provides relevant clinical data as a resource to the clinician and is not intended to be a source of medical advice or to determine or recommend a course of action or treatment for a patient.